Skip to main content
J

JIANGSU HUIFENG BIO AGRICULTURE CO., LTD. — Investor Relations & Filings

Ticker · 002496 LEI · 300300X6JZ0Q0XWG8W89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,838 across all filing types
Latest filing 2026-04-17 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002496

About JIANGSU HUIFENG BIO AGRICULTURE CO., LTD.

https://www.hfagro.com

Jiangsu Huifeng Bio Agriculture Co., Ltd. specializes in the research, development, production, and distribution of crop protection products. The company offers a diverse portfolio of pesticides, including fungicides, herbicides, and insecticides, with a focus on high-purity active ingredients and specialized formulations. Key products include prochloraz, epoxiconazole, bromoxynil, and quizalofop-p-ethyl. The organization integrates advanced chemical synthesis with biological agriculture initiatives to provide sustainable solutions for modern farming. Its operations cover the full manufacturing cycle, from technical grade production to the development of finished crop protection agents. The company serves global markets, delivering technical expertise and customized agricultural solutions to enhance crop yields and manage pest resistance.

Recent filings

Filing Released Lang Actions
独立董事2025年度述职报告-李昌莲
Governance Information Classification · 1% confidence The document is a standalone 2025 annual duty report (“述职报告”) by an independent director of the company, describing governance activities, meeting attendance, independent opinions, and compliance with laws and internal rules. It is not a financial report, earnings release, or capital announcement, but rather a governance-related disclosure about the director’s duties and company board governance practices. This aligns with the Governance Information category (CGR).
2026-04-17 Chinese
关于举办2025年度网上业绩说明会的公告
Investor Presentation Classification · 1% confidence The document is a corporate announcement of an upcoming 2025 online performance explanation meeting (网上业绩说明会) to communicate annual results and strategy with investors. It is not the annual report itself, nor a simple regulatory notice or report publication alert. It constitutes an investor presentation event. Therefore, it best fits the Investor Presentation category (IP).
2026-04-17 Chinese
关于2025年度利润分配预案的公告
Notice of Dividend Amount Classification · 1% confidence The document is a company announcement outlining the annual profit distribution proposal (‘利润分配预案’) for 2025, namely that no cash dividends, stock dividends or capital reserve transfers will be made due to losses. This fits the ‘Notice of Dividend Amount’ category (DIV), as it communicates the details of the dividend/distribution plan to shareholders.
2026-04-17 Chinese
独立董事2025年度述职报告-杨兆全
Governance Information Classification · 1% confidence The document is an Independent Director’s 2025 annual duty report (“独立董事述职报告”) detailing attendance at board and shareholder meetings, issuance of independent opinions, committee work, and governance oversight activities. It is not a financial results announcement, capital update, dividend notice, or change in board composition; rather it focuses on corporate governance practices and board oversight. This aligns with the Governance Information category (CGR).
2026-04-17 Chinese
关于开展期货套期保值业务的可行性分析报告
Regulatory Filings Classification · 1% confidence The document is a feasibility analysis report for the company's commodity futures hedging business, outlining necessity, feasibility, organizational structure, risk analysis, and control measures. It is not an earnings release, annual or interim report, proxy materials, capital raise announcement, M&A document, dividend notice, or other defined category. It appears as a formal corporate disclosure without fitting the specific categories, making it a general regulatory filing (RNS).
2026-04-17 Chinese
关于申请撤销退市风险警示及其他风险警示的公告
Regulatory Filings Classification · 1% confidence The document is an announcement by a listed Chinese company regarding its application to the Shenzhen Stock Exchange to revoke the “delisting risk warning” and “other risk warning” status. It is not an actual delisting notice (DLST) since the stock is not being removed; nor is it a financial report itself (10-K, IR), a dividend notice, M&A, or similar. It is a regulatory status update that does not neatly fit other specific categories, making it a general regulatory filing (RNS).
2026-04-17 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.